Wednesday, August 9, 2023

Hiv Treatment In Delhi Book Online Appointment

 

PEP Treatment in Delhi is a medical treatment that involves taking antiretroviral medications to prevent the potential transmission of HIV after a possible exposure. PEP is typically recommended for individuals who have been exposed to HIV through activities such as unprotected sexual intercourse, needle stick injuries, or other forms of potential contact with the virus.

 


Here are some key points about PEP treatment:

 

·        Timing: PEP should be started as soon as possible after the potential exposure to HIV, preferably within hours and no later than 72 hours (3 days) after the exposure. The earlier it is initiated, the more effective it is likely to be.

 

·        Duration: PEP usually involves taking a combination of antiretroviral medications for 28 days. Adhering to the prescribed regimen is crucial for the treatment's effectiveness.

 

·        Medications: The exact combination of antiretroviral medications used for PEP can vary. Commonly used medications may include those from classes like nucleoside reverse transcriptase inhibitors (NRTIs) and integrase strand transfer inhibitors (INSTIs). The specific medications used will depend on factors such as the source of exposure and individual health considerations.

 

·        Effectiveness: PEP significantly reduces the risk of HIV transmission when taken correctly and within the recommended timeframe. However, it is not 100% effective, and its effectiveness depends on various factors including how soon it is started after exposure.

 

·        Consult a Healthcare Professional: PEP is a medical intervention that should only be initiated and monitored by a qualified healthcare professional. If you believe you've been exposed to HIV, it's important to seek medical attention promptly to discuss the need for PEP.

 

·        Side Effects: Like any medication, antiretroviral used for PEP can have potential side effects. These can vary based on the specific medications used and individual factors. A healthcare provider will discuss potential side effects and how to manage them.

 

·        Follow-Up Testing: After completing the PEP regimen, individuals are typically advised to undergo follow-up HIV testing to ensure that the treatment was successful in preventing infection.

 

Remember, PEP is not a substitute for consistent and proper use of preventive measures such as condoms and safer injection practices. If you believe you've been exposed to HIV, it's important to seek medical attention as soon as possible to discuss your situation with a healthcare professional and determine if PEP is appropriate for you.

 

Certainly, here's some additional information about post-exposure prophylaxis (PEP):

 

 

·        Eligibility: PEP is recommended for individuals who have had a significant exposure to HIV, such as unprotected sexual intercourse with a partner of unknown HIV status, sharing needles with someone who is HIV-positive, or being the recipient of a needle stick injury in a healthcare setting.

 

·        Initial Assessment: When you seek PEP, a healthcare provider will assess the nature of the exposure, the potential risk, and your individual health factors to determine if PEP is appropriate for you.

 

·        Prescription and Medication Adherence: If PEP is deemed necessary, your healthcare provider will prescribe a combination of antiretroviral medications. It's crucial to take the medications exactly as prescribed and to complete the full course, even if you experience side effects.

 

·        Side Effects: Common side effects of PEP medications can include nausea, diarrhea, fatigue, and headache. Not everyone experiences side effects, and they are generally manageable. Your healthcare provider can provide guidance on managing side effects.

 

·        Regular Monitoring: During the PEP treatment period, your healthcare provider may schedule follow-up appointments to monitor your health and ensure that the medications are being tolerated well.

 

·        HIV Testing: PEP treatment does not immediately prevent HIV infection, and it's important to continue practicing safe behaviors during and after the treatment. After completing the PEP regimen, you'll be advised to undergo HIV testing at specific intervals to confirm that you remain HIV-negative.

 

·        Availability: PEP medications are prescription drugs, and their availability may vary based on location and healthcare settings. If you suspect you need PEP, seek medical care promptly.

 

·        Cost and Insurance: The cost of PEP medications and medical visits can vary. Some insurance plans may cover the cost, but it's important to check with your provider and understand your coverage.

 

·        Prevention Methods: While PEP is an important option for reducing the risk of HIV transmission after potential exposure, the best way to prevent HIV is to practice safer behaviors consistently. This includes using condoms during sexual activity, not sharing needles, and considering pre-exposure prophylaxis (PrEP) for individuals at higher risk.

 

·        Confidentiality: Healthcare providers understand the sensitive nature of seeking PEP. They are committed to maintaining your privacy and confidentiality throughout the process.

 

 

If you believe you've been exposed to HIV, it's essential to seek medical care promptly. PEP is time-sensitive and is most effective when started as soon as possible after the exposure. Contact a healthcare professional or a healthcare facility to discuss your situation and determine the appropriate steps to take.

 

 

 

 

Dr. Raina’s Safe Hands Clinic

Dr. Vinod Raina HIV Doctors in Gautam Nagar

Contact Us-9136363692 | 9871605858

Address: — Saket E-34, Ekta Apartments near

Malviya Nagar Metro Station Gate No-4 New Delhi-110017

Monday, July 17, 2023

Best Hiv Human Immunodeficiency Virus Treatment

HIV Treatment in Delhi stands for Human Immunodeficiency Virus, which is a virus that attacks the body's immune system, specifically the CD4 cells (T cells), weakening its ability to fight off infections and diseases. If left untreated, HIV can lead to the disease known as Acquired Immunodeficiency Syndrome (AIDS).

Here's an overview of HIV, including its symptoms, causes, diagnosis, treatment, and prevention:

Symptoms:

In the early stages of HIV infection, many people may not experience any noticeable symptoms, or they might have flu-like symptoms that can be easily mistaken for other illnesses. Common symptoms include fever, fatigue, swollen lymph nodes, sore throat, headache, muscle aches, and rash. As the infection progresses, more severe symptoms may develop, such as persistent diarrhea, weight loss, night sweats, and opportunistic infections.

 


1.      Stages of HIV Infection:

HIV infection progresses through several stages:

·      Acute HIV infection: This occurs within 2 to 4 weeks after initial exposure to the virus. During this stage, the viral load is very high, and the person may experience flu-like symptoms. HIV antibody tests may not detect the infection during this period.

·      Clinical latency (chronic HIV infection): After the acute stage, the virus enters a period of clinical latency, which can last for several years. During this stage, the virus continues to replicate but at lower levels. People may not have any symptoms or experience mild ones.

·      Symptomatic HIV infection: As the immune system weakens over time, symptoms may start to appear, indicating a more advanced stage of the disease. These symptoms may include persistent infections, weight loss, and other opportunistic infections.

·      Acquired Immunodeficiency Syndrome (AIDS): When the CD4 cell count falls below a certain level and the immune system becomes severely compromised, the infection progresses to AIDS. At this stage, people become highly susceptible to opportunistic infections and certain cancers.

2.      Opportunistic Infections and AIDS-Defining Illnesses:

As HIV weakens the immune system, it leaves the body vulnerable to opportunistic infections and certain illnesses that are more severe and less common in individuals with healthy immune systems. Some examples of AIDS-defining illnesses include:

·        Pneumocystis pneumonia (PCP)

·        Kaposi's sarcoma

·        Cytomegalovirus (CMV) infection

·        Tuberculosis (TB)

·        Toxoplasmosis

·        Cryptococcus meningitis

3.      U=U (Undetectable = Untransmittable):

One of the most significant advancements in HIV prevention is the concept of U=U, which means that an HIV-positive person with an undetectable viral load through effective ART cannot transmit the virus sexually. Studies have shown that when the virus is suppressed to undetectable levels in the blood, the risk of sexual transmission is negligible.

4.      HIV Vaccine Research:

Researchers continue to work on developing an effective HIV vaccine to prevent new infections. While there have been significant advancements in vaccine development, creating an effective vaccine remains a complex challenge due to the virus's ability to mutate rapidly and evade the immune system.

Causes:

HIV is primarily transmitted through the exchange of certain bodily fluids, including blood, semen, vaginal fluids, rectal fluids, and breast milk. The most common modes of transmission are:

·        Unprotected sexual intercourse with an infected partner.

·        Sharing needles or syringes with someone who has HIV.

·        From an HIV-positive mother to her child during childbirth or breastfeeding.

·       Rarely, through transfusions of infected blood or blood products (in regions where blood screening is not practiced).

Diagnosis:

HIV can be diagnosed through various tests that detect the presence of HIV antibodies or the virus itself. Common tests include:

·      HIV Antibody Test: This test looks for antibodies that the body produces in response to HIV infection. It is usually done with a blood sample or oral fluid swab.

·     HIV RNA Test: This test detects the actual virus in the blood and is used to diagnose early infections when antibodies may not be present yet.

Treatment:

While there is no cure for HIV, it can be effectively managed with antiretroviral therapy (ART). ART is a combination of different antiretroviral drugs that help suppress the virus, reduce its replication, and slow down the progression of the disease. With proper adherence to ART, people with HIV can lead relatively healthy lives and reduce the risk of transmitting the virus to others.

Prevention:

Preventing HIV transmission involves adopting various strategies:

·     Practicing safe sex: Use condoms or dental dams during sexual intercourse, especially with new or unknown partners.

·       Avoiding sharing needles: If injecting drugs, use clean needles and syringes.

·   Pre-exposure prophylaxis (PrEP): This involves taking antiretroviral medications regularly if you are at high risk of HIV infection.

·      Post-exposure prophylaxis (PEP): After potential exposure to HIV, PEP involves taking antiretroviral medications within 72 hours to reduce the risk of infection.

·  HIV testing: Regular testing helps identify infections early and prevents further transmission.

It's essential to raise awareness about HIV, reduce stigma, and promote access to testing and treatment to combat the virus effectively. If you suspect you may have been exposed to HIV or are experiencing symptoms, it's crucial to seek medical advice and get tested as soon as possible. It's important to remember that HIV is a manageable condition, and with early diagnosis, access to proper medical care, and consistent treatment, people living with HIV can lead long, healthy lives. Education, awareness, and a commitment to practicing safe behaviors are essential in reducing the prevalence of HIV and stopping the spread of the virus.

 




 

Dr. Raina’s Safe Hands Clinic

Dr. Vinod Raina HIV Doctors in Sant Nagar

Contact Us-9136363692 | 9871605858

Address: — Saket E-34, Ekta Apartments near

Malviya Nagar Metro Station Gate No-4 New Delhi-110017

Thursday, April 20, 2023

CD4 Count HIV Treatment in Delhi

You can boost your CD4 count by receiving antiretroviral therapy (ART), which is HIV Treatment in Delhi (human immunodeficiency virus).

CD4 cells are white blood cells that aid your immune system in the battle against illnesses. By eliminating immune system cells, HIV undermines the body's defenses against sickness.

Antiretroviral therapy is a treatment plan that entails taking a daily mix of medications that work together to prevent HIV from creating new viral cells, thereby lowering your viral load. When the medications reduce HIV levels in the body and fewer viral cells attack CD4, more CD4 cells can survive and combat infections. The immune system has more time to recover and manufacture new CD4 cells without the harm caused by HIV cells.

Your CD4 count should begin to rise soon after you begin ART medication.

Most patients' CD4 counts will rapidly increase within the first three months of antiretroviral medication.

The amount of CD4 cells per cubic millimeter (mm3) of blood tends to grow by 50 to 150 cells per year of treatment.

With regular treatment, CD4 levels can often improve for more than a decade.

When CD4 Levels Do Not Rise

Antiretroviral therapy may not enhance CD4 counts as expected in a small number of patients, but there are strategies to improve the chances of success.

One of the most crucial aspects is timing. Beginning treatment as soon as feasible after diagnosis, when one's CD4 count is still intact, is connected with significantly better outcomes. After starting treatment, if CD4 counts are already low (less than 200 cells per mm3 of blood), the medications may struggle to produce a meaningful rise. Therapy may fail to raise CD4 counts to a healthy level in 15 to 20% of patients who begin with a very low number of CD4 cells.

If you’re CD4 counts stay low despite treatment, your doctor will likely investigate possible causes, such as specific drugs, untreated infections, or other illnesses. Yet, antiretroviral medication is the only known strategy to boost your CD4 count.

Low CD4 Count Symptoms

A low CD4 count does not cause specific symptoms in and of itself, but it leaves people with HIV extremely prone to getting an opportunistic infection, which is the term for diseases caused by microorganisms that frequently prey on people with weakened immune systems. The body has a harder time fighting infections when CD4 cell numbers are low. Infectious infections rarely affect those who have a strong immune system. Instead, they target those who have impaired immune systems as a result of HIV or other causes.

Opportunistic infections come in a variety of forms. The following are some of the most prevalent varieties and their associated symptoms:

Candidacies

·        Tongue variations (white patches, redness)

·        Mouth ache

·        Taste evolves

·        Appetite problems

·        Yeast infections in the vaginal cavity

Herpes simplex virus (HSV)

·        Sores around the mouth, genitals, or the anus

Salmonella

·        Fever

·        Diarrhea

Toxoplasmosis

·        Headache

·        Vision shifts

·        Confusion

·        Seizures

What is the reason of a low CD4 count?

HIV reaches out and attaches to CD4 cells once inside the body. The virus then modifies the genetic material within the infected cell, transforming it into an HIV-producing factory capable of manufacturing and releasing new copies of the virus.

HIV-infected CD4 cells are defective and damaged. Many of these cells perish at a young age. When more copies of the virus are produced, more CD4 cells are killed, leaving the immune system with few CD4 cells on which to rely. The immune system's defenses are significantly weakened when there aren't enough CD4 cells, leaving the body exposed to infections.

What would be the Treatment for a Low CD4 Count?

Treatment of the underlying condition can improve a low CD4 level. Everybody infected with HIV, including those with a low CD4 count, receives antiretroviral medication, or ART.

Antiretroviral therapy consists of a cocktail of antiretroviral, sometimes known as ARVs. These medications lower HIV levels in the body by preventing the virus from reproducing (viral load). More CD4 cells can survive when the virus load falls.

HIV Medications are classified into seven categories or "classes" that function in somewhat different ways:

·        Inhibitors of nucleoside reverse transcriptase (NRTIs)

·        Reverse transcriptase inhibitors that are not nucleosides (NNRTIs)

·        Inhibitors of strand transfer by integrate (INSTIs)

·        Inhibitors of proteases (PIs)

·        antagonists of CCR5

·        Inhibitors of fusion

·        Post-adhesion inhibitors

An antiretroviral therapy regimen typically consists of three medications, at least one of which is from a different class than the others. Mixing treatments with different mechanisms improves treatment efficacy and prevents the virus from acquiring resistance to the medications.

HIV therapy is lifelong, and consistency is the key to treatment effectiveness. Beginning antiretroviral therapy as soon as feasible, taking the pills on a daily basis, and seeing a doctor on a regular basis all help to keep the virus at bay. Only by suppressing the viral load can CD4 cell numbers improve.

 

 

Dr. Raina’s Safe Hands Clinic

Dr. Vinod Raina HIV Doctors in Paschim Vihar

Contact Us-9136363692 | 9871605858

Address: — Saket E-34, Ekta Apartments near

Malviya Nagar Metro Station Gate No-4 New Delhi-110017

Saturday, March 18, 2023

Best Aids Doctor in Delhi NCR Dr. Raina's Safe Hands

Where did HIV originate?

A particular kind of chimpanzee in Central Africa is where humans first contracted HIV. According to studies, the human-chimpanzee transmission of HIV may have begun as early as the late 1800s.

The virus that affects chimpanzees is known as simian immunodeficiency virus. When people killed these chimpanzees for food and came into contact with their sick blood, it was likely transmitted to humans.

Over many years, Best HIV Doctor in Delhi gradually spread throughout Africa and then to other regions of the world. 


 

How the body contracts HIV

If the HIV virus enters our bloodstream, it can lead to an HIV infection.

Our immune system, which is the area of our body that maintains your health, is then infected.

To avoid being detected and eliminated by human immune system, it accomplishes this by entering T-helper cells, commonly known as CD4 cells. Afterwards it replicates itself in order to infect additional cells.

The HIV lifecycle is how the virus multiplies in human bodies and is known as such.

Antiretroviral medications (ARVs) are the only option to stop the HIV lifecycle and maintain good health.

What phases of the HIV lifecycle are there?

The four stages of the HIV lifecycle are as follows. Each of them involves a variety of activities that take place inside and around human CD4 cells.

What takes place during the stage of binding and fusion?

The HIV virus binds to a T-helper cell. It then unites to it and releases its genetic information into the cell.

Fusion or entry inhibitor medicines are the classes of ARVs that block this stage of the lifecycle. They prevent HIV from getting inside the cell. If these ARVs are the best choice for you, your healthcare practitioner will let you know.

What transpires during the integration and reverse transcription stages?

Reverse transcription is the mechanism by which HIV transforms its genetic material into HIV DNA once it has entered the T-helper cell. The new HIV DNA then makes its way into the host cell's nucleus and seizes control.

Over the past ten years, both the efficiency of ARVs in treating HIV infection and their accessibility globally has significantly grown. ARV clinical trials are still ongoing, with a focus on examining newer ARVs and the relative risks and benefits of various combinations.

Depending on a person's medical history, other illnesses, prior therapies, disease stage, and personal preferences, the best HIV treatment plan should be tailored to them specifically. The ramifications of having HIV infection, as well as the advantages and potential negative effects of ARV regimens, should be thoroughly discussed with those who have HIV.      

 


 

Dr. Raina’s Safe Hands Clinic

Dr. Vinod Raina HIV Doctors in East Of Kailash

Contact Us-9136363692 | 9871605858

Address: — Saket E-34, Ekta Apartments near

Malviya Nagar Metro Station Gate No-4 New Delhi-110017

 

Saturday, February 11, 2023

HIV Doctor in Delhi/NCR HIV Testing & Counselling

An explosion of knowledge in the fields of HIV virology, pathogenesis (both immunologic and virological), treatment of HIV disease, therapy and prophylaxis of HIV-associated opportunistic infections, and HIV prevention has coincided with the remarkable global spread of the HIV epidemic. Given the vast and expanding body of knowledge about PEP Treatment in Delhi, it is essentially difficult for a general practitioner in healthcare to stay current with the most recent findings. This chapter's objective is to present the most recent data on the pandemic's scope, pathophysiology, treatment, and prevention, as well as its potential for vaccine development. Above all, the objective is to offer a solid scientific framework and practical therapeutic recommendations for an up-to-date strategy for HIV care.

The current CDC categorization system for HIV infection and AIDS groups patients according to their clinical HIV-related symptoms and CD4+ T lymphocyte counts. There are five stages of an established HIV infection (0, 1, 2, 3, or unknown). The stage is 0 and will stay that way for another 6 months if a negative HIV test was achieved within 6 months of the first HIV infection diagnosis. Advanced HIV disease (AIDS) is classified as stage 3 if one or more distinct opportunistic illnesses have been identified. Otherwise, the stage is determined by immunologic characteristics and the results of the CD4+ T lymphocyte test. The intricate and lengthy diagnostic and staging criteria for AIDS were created for surveillance rather than for actual patient management.

 


 

AGENTS OF ETIOLOGY

The human retrovirus family Retrovirus and the Lent viruses subfamily contain HIV, which is the cause of AIDS. Nononcogenic lentiviruses are present in nonhuman primates, cats, horses, sheep, goats, and cattle. The two retroviruses known to cause human disease are the human T lymphotropic viruses (HTLV)-1 and HTLV-2, which are transforming retroviruses, and the human immunodeficiency viruses, HIV-1 and HIV-2, which either directly or indirectly create psychopathic effects. The majority of HIV infections worldwide, including unquestionably in the United States, are caused by HIV-1, which has a number of sub types with distinct regional distributions. HIV-2 was initially isolated to West Africa, where it was first identified in patients in 1986. On the other side, there have been numerous reports of cases connected to West Africa or sexual interaction with people from that region. Most likely, the HIV-1 groups M, N, O, and P, as well as the HIV-2 groups A through H, were independently transferred from nonhuman primate reservoirs to humans. The most likely sources of HIV-1 and HIV-2 transmission were chimpanzees, gorillas, and/or sooty manages. The main factor causing the AIDS pandemic is the HIV-1 M group viruses. Although the HIV-1 group O and HIV-2 viruses have been found in many countries, including the developed world, they have produced much less severe epidemics. Group N and P virus infections are infrequent and almost exclusively affect residents of Cameroon or Cameroonian travellers.

HIV MORPHOLOGY

According to electron microscopy, the HIV virion has an icosahedral form with numerous outside spikes made by the two main envelope proteins, external gp120 and transmembrane gp41. A trimeric heterodimer in three dimensions makes up the HIV envelope. After emerging off the surface of the infected cell, the virion creates a lipid bilayer that includes a variety of proteins from the host cell.

Precursors to HIV include:

 

• Headache.

• Fatigue.

• Muscle aches.

• A throat ache.

• Lymph node swelling.

• A red, non-itching rash that typically appears on your torso.

• Fever.

• Sores or ulcers in your genitalia, oesophagus, mouth, or anus.


TRANSMISSION OF SEX

 

HIV infection is largely a sexually transmitted disease in the majority of the world (STI). Even while male-to-male sexual transmission is more common in many Western nations, heterosexual transmission is by far the most common way for an infection to spread, especially in developing nations. Although many factors, such as viral load and the frequency of ulcerative genital diseases, affect the effectiveness of heterosexual HIV transmission, such transmission is frequently inefficient. A recent systematic investigation revealed a low per-act likelihood of heterosexual transmission in the absence of antiretroviral therapy or condom use: 0.04 percent for female-to-male transmission and 0.08 percent for male-to-female transmission during vaginal intercourse. Seminal fluid from both infected and uninfected women has tested positive for HIV.

mononuclear cells and a material devoid of cells When lymphocytes and monocles are in excess in the seminal fluid, as is the case with genital inflammatory illnesses such arthritis and epidemiologist, which are strongly related to other STIs, the virus appears to concentrate there. The virus has been found in both vaginal fluid and cervical smears. Unprotected receptive anal intercourse (URAI) carries a higher risk of HIV transmission in both men and women than unprotected receptive vaginal intercourse (URVI). The per-act risk of HIV transmission via URAI has been estimated to be 1.4% despite the paucity of data. The risk of HIV acquisition associated with URAI is higher than that seen with penile-vaginal intercourse because only a thin, fragile rectal mucosal membrane separates the deposited semen from potentially susceptible cells in and beneath the mucous, and micro-trauma of the mucosal membrane has been linked to anal intercourse.

 

 

 

Dr. Raina’s Safe Hands Clinic

Dr. Vinod Raina HIV Doctors in Badarpur

Contact Us-9136363692 | 9871605858

Address: — Saket E-34, Ekta Apartments near

Malviya Nagar Metro Station Gate No-4 New Delhi-110017